Remove Heart Failure Remove Heart Rhythm Remove Hospital
article thumbnail

First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology

DAIC

milla1cf Tue, 06/11/2024 - 18:09 June 11, 2024 — Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has established the first robotic cardiac heart program in Southern Italy.

article thumbnail

Clinical Trial Presented at HRS 2024 Shows Benefits of Early Cardiac Resynchronization Therapy (CRT) in Slowing Progression of Heart Failure

DAIC

The findings were presented during the final day of the Heart Rhythm Society meeting, HRS 2024. have heart failure, and the prevalence is expected to rise to 8.5 1 Additionally, more than 30% of heart failure patients have conduction abnormalities. Approximately 6.7 million adults in the U.S.

article thumbnail

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

DAIC

milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.

article thumbnail

Top 10: Must-reads from the Month of May

DAIC

American College of Cardiology (ACC) and American Heart Association (AHA) Issue New Hypertrophic Cardiomyopathy (HCM) Management Guidelines 2. New Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treatment Over the Past 20 Years, Management Remains Unchanged 3.

article thumbnail

News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation

DAIC

Four heart rhythm organizations from around the globe developed the statement. It is also published in Heart Rhythm , the official journal of the HRS, Journal of Arrhythmia , the official journal of the APHRS, and Journal of Interventional Cardiac Electrophysiology , the official journal of the LAHRS.

article thumbnail

CVRx Announces Availability of Additional Data Supporting Long-term Benefits of Barostim

DAIC

a commercial-stage medical device company, announced today the availability of additional data, including the publication of results of the post-market phase of the BeAT-HF trial in the European Journal of Heart Failure. The manuscript is available online at the European Journal of Heart Failure website.

article thumbnail

What Happens During Electrical Cardioversion?

AMS Cardiology

Cardioversion is used to correct abnormal heart rhythms, also known as arrhythmias. When your heart beats too quickly, too slow, or irregularly, it can affect your blood flow and lead to severe complications like stroke or heart failure. Cardioversions can help “reset” your heart rhythm to its regular pattern.